QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in an early study.
The scientist Stephen Hawking lived with amyotrophic lateral sclerosis (ALS), the most common type of motor neuron disease, ...
Developing motor neurons from stem cells taken directly from amyotrophic lateral sclerosis (ALS) patients offers new hope for better understanding and treatment of the fatal neurodegenerative disorder ...
A funding boost of more than £78 million will help UCL scientists working to develop a potential treatment for motor neurone disease, for which there is currently no cure and which affects 5,000 ...
The findings of this case-control study suggest that air pollution, even at relatively low levels typical of Sweden, may contribute ...
A new study from Sweden links long-term air pollution exposure to higher risk of motor neurone disease and faster progression ...